Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7368 p361
24 September 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Drug pictograms can improve compliance

A “universally acceptable” system of pictograms to supplement spoken directions and written labels in emergencies has been developed by the Military and Emergency Pharmacy Section (MEPS) of the International Pharmaceutical Federation.

The system was developed because poor communication between prescribers and patients can cause confusion over the correct use of medicines in emergency situations. It was presented during the World Congress of Pharmacy and Pharmaceuticals in Cairo earlier this month.

FIP says the initiative, which originated with the military members of the MEPS, is based on a story-board concept and covers the indications, dosages, frequency and special instructions associated with a medicine. Cultural issues are taken into consideration. FIP believes that the initiative will increase compliance with medication at low cost.

An extensive field trial was undertaken recently to test and evaluate the scheme in collaboration with the Canadian African Health Alliance with a group of around 500 patients. With one exception, all the pictograms tested reached the European Commission’s standard of more than 80 per cent comprehension.

The vision is for medicines packaging to be labelled with graphics, which are highlighted to indicate their full meaning. For example, a silhouette of a human figure can be marked to show the part of the body being treated. The time of day to take the medicine is shown with pictures of the sun and the moon, and the number of tablets to be taken indicated pictorially.

FIP hopes to produce sets of pictographic labels in collaboration with the International Pharmacy Students Federation. The project is being handled through the FIP Board of Pharmaceutical Practice and is being offered to the World Health Organization for further development.

Notice-board, p366

Back to Top


©The Pharmaceutical Journal